NCT06320015 Emergency Medicine Peer Outreach Worker Engagement for Recovery
| NCT ID | NCT06320015 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Substance Use Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-07-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational, prospective case-control study evaluating the effects of an emergency department community health worker-peer recovery specialist program (PCHW), the Substance Misuse Assistance Response Team (SMART). Aims of this study are to 1) understand participant experiences working with a SMART PCHW and identify possible mechanisms for successful recovery linkage; 2) Evaluate SMART effectiveness on patient-centered outcomes, building recovery capital, and recovery linkage; 3) Evaluate SMART implementation and effectiveness on patient outcomes over time. Using a combination of surveys and data linkages to state administrative databases, study investigators will prospectively compare changes in addiction treatment engagement, recovery capital, health related social needs, acute care utilization, and death between people receiving a ED PCHW and those who do not. After consenting to study participation, participants will complete surveys at time of study enrollment and 3 and 6 months after their initial ED visit. Primary outcomes include engagement in addiction treatment, social services engagement, acute care utilization, and mortality will be assessed through linkages to state administrative databases.
Eligibility Criteria
Inclusion Criteria: 1. Adults 18 years old or older 2. Seen and treated at Rhode Island or The Miriam Hospital ED for a substance use-related concern including intoxication, withdrawal, opioid overdose, opioid withdrawal, or substance use-related infection 3. Able to provide informed consent 4. Able to provide at least two forms of contact (personal phone, social media, email, or contact information for family or friends) 5. Participants may speak languages other than English but require use of interpreter services. Consents will be available in English, Spanish, and Portuguese, the three most spoken languages in the Providence metropolitan area. Exclusion Criteria: 1. Unable to provide informed consent 2. In police custody, incarcerated, or have a court ordered treatment enrollment
Contact & Investigator
Elizabeth Samuels, MD, MPH, MHS
PRINCIPAL INVESTIGATOR
UCLA Emergency Medicine
Frequently Asked Questions
Who can join the NCT06320015 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06320015 currently recruiting?
Yes, NCT06320015 is actively recruiting participants. Contact the research team at agaipo@lifespan.org for enrollment information.
Where is the NCT06320015 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT06320015 clinical trial?
NCT06320015 is sponsored by University of California, Los Angeles. The principal investigator is Elizabeth Samuels, MD, MPH, MHS at UCLA Emergency Medicine. The trial plans to enroll 400 participants.